Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Beer compound could help fend off Alzheimer's and Parkinson's diseases

  • Novel radioguided brain surgery technique could help pinpoint cancerous tissue

  • Concentrating on word sounds helps reading instruction and intervention

  • Molecular alterations in head and neck cancers uncovered by study

  • Why upper motor neurons degenerate in ALS

  • Cell imaging gets colorful

  • New theoretical framework for future studies of resilience

  • Playing with puzzles, blocks may build children's spatial skills

  • Intracranial stimulation proved efficient in the recovery of learning and memory in rats

  • New biological evidence reveals link between brain inflammation and major depression

  •